CMV Infection: A Clinical Challenge in Biological Therapy? The Case of Asymptomatic Patients with Persistent Positive Immunoglobulin M Anti-CMV Treated with Secukinumab

The use of biological therapy is now common practice in the treatment of immune-mediated inflammatory diseases (IMID). Currently, there are no guidelines related to the management of cytomegalovirus (CMV) infections or reactivation during therapy with biological agents. Furthermore, there is a lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambardella, Alessio, Licata, Gaetano, Calabrese, Giulia, De Rosa, Alina, Pagliuca, Francesca, Alfano, Roberto, Argenziano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711202/
https://www.ncbi.nlm.nih.gov/pubmed/33282718
http://dx.doi.org/10.2147/PTT.S284701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711202/
https://www.ncbi.nlm.nih.gov/pubmed/33282718
http://dx.doi.org/10.2147/PTT.S284701

Ejemplares similares